Develops innovative bladder-sparing immunotherapies to improve outcomes and quality of life for bladder cancer patients.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CG Oncology is focused on developing and delivering innovative bladder-sparing immunotherapies for patients with bladder cancer. The company is advancing a pipeline of oncolytic immunotherapies designed to improve quality of life and outcomes for those affected by bladder cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CG Oncology Management Team
CG Oncology Valuations & Financials
View real-time NPM data on CG Oncology stock including daily CG Oncology stock price estimates, valuation history, and historical share price information. Access CG Oncology financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CG Oncology pricing across six independent market signals. Looking for private company due diligence data sources on CG Oncology? Get in touch to learn more.
Similar Companies
like CG Oncology
Ollin Biosciences
Healthcare & Life Sciences
Develops antibody therapies targeting multiple disease pathways to improve treatment efficacy in ophthalmic diseases.
Dash Bio
Healthcare & Life Sciences
Accelerates clinical bioanalysis that integrates AI‑driven robotics and software to deliver fast, high‑quality assays for drug development.
CapsoVision
Healthcare & Life Sciences
Develops advanced capsule endoscopy systems with 360° imaging technology for gastrointestinal diagnostics and cloud-based result management.
Sunbird Bio
Healthcare & Life Sciences
Develops blood-based diagnostic tests that detect protein properties for earlier, more accurate diagnosis of neurological disorders and cancer.
Cadence Neuroscience
Healthcare & Life Sciences
Provides digital tools that quantify brain function and cognitive health for more precise clinical assessment and tracking.
Glimpse
Healthcare & Life Sciences
Delivers X-ray scanning tools for internal defect detection and factory-grade assurance workflows.
Stramsen Biotech
Healthcare & Life Sciences
Develops plant-based medicines targeting various diseases, aiming to offer safer and more effective treatments with reduced side effect
Supira Medical
Healthcare & Life Sciences
Develops devices that provide temporary heart support during procedures, improving blood flow and enabling safer, more effective treatment.
Genvax Technologies
Healthcare & Life Sciences
Developing that delivers customizable animal vaccines through a self‑amplifying RNA platform tailored to evolving disease variants.
FAQ
We have answers
CG Oncology stock does not trade on public stock exchanges. CG Oncology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CG Oncology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CG Oncology Stock does not trade on public stock exchanges. In order to sell CG Oncology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CG Oncology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CG Oncology share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CG Oncology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CG Oncology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CG Oncology stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CG Oncology is a private company and has not had an IPO. There is currently no CG Oncology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CG Oncology IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
